ELBASVIR AND GRAZOPREVIR (ZEPATIER) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the generic name?

ELBASVIR AND GRAZOPREVIR

What is the Trade Name for ELBASVIR AND GRAZOPREVIR?

ZEPATIER

What are the Indications for ELBASVIR AND GRAZOPREVIR?

  • 1 INDICATIONS AND USAGE ZEPATIER ¬Æ is indicated for the treatment of chronic hepatitis C virus (HCV) genotype 1 or 4 infection in adult and and pediatric patients 12 years of age and older or weighing at least 30 kg. ZEPATIER is indicated for use with ribavirin in certain patient populations [see Dosage and Administration (2.2) ] . ZEPATIER is a fixed-dose combination product containing elbasvir, a hepatitis C virus (HCV) NS5A inhibitor, and grazoprevir, an HCV NS3/4A protease inhibitor, and is indicated for treatment of chronic HCV genotype 1 or 4 infection in adult and pediatric patients 12 years of age and older or weighing at least 30 kg. ZEPATIER is indicated for use with ribavirin in certain patient populations. ( 1 )

 

View Our Nursing Pharmacology Course


 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.